Innovative Imaging VerAvanti’s Scanning Fiber Endoscope (SFE) targets high‑resolution intravascular visualization to enable earlier disease characterization and intervention confidence, presenting a clear opportunity for sales discussions with vascular, neurovascular, and interventional cardiology teams seeking next‑gen imaging capabilities.

Clinical Differentiation Position the SFE as a forward‑looking imaging modality that extends beyond anatomy to vessel‑level pathology, aligning with hospitals and clinics pursuing precision diagnostics and value‑based care through improved risk assessment and treatment planning.

Growth Funding Series A funding of 31.5M signals investor confidence and potential for accelerated product development, partnerships, and market entry strategies; target medical centers and distributors looking for innovative equipment with strong growth potential.

Award Momentum Recognition as a finalist for Innovation of the Year at the 2026 GeekWire Awards enhances credibility for outreach to large health systems, procurement teams, and key opinion leaders seeking innovative device suppliers.

Early Stage Opportunity With a focus on cardiovascular, neurovascular, and peripheral applications and a modest company size, there is room to engage regional hospitals, academic centers, and vascular labs for pilot studies, clinical trials, and early adopters to demonstrate value and drive adoption.